StockData
Harvard Apparatus Regenerative Technology, Inc. logo

Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock

HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$2.21−0.02 (-0.72%)

Close on Oct 19, 2026Market cap $38.92MP/E –Yield –

Harvard Apparatus Regenerative Technology r&d expenses

Research and development expenses are spending on new products and technology.

Harvard Apparatus Regenerative Technology's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.87M, up 34.8% year over year. For fiscal 2025 it was $2.65M, up 14.8% from the year before. Over ten years it grew -5.7% a year on average. The highest annual figure on record is $7.60M in fiscal 2016.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.65M+14.8%
FY2024Dec 31, 2024$2.31M-24.6%
FY2023Dec 31, 2023$3.06M+75.8%
FY2022Dec 31, 2022$1.74M+9.4%
FY2021Dec 31, 2021$1.59M-23.1%
FY2020Dec 31, 2020$2.07M-57.4%
FY2019Dec 31, 2019$4.85M+23.9%
FY2018Dec 31, 2018$3.92M-48.4%
FY2017Dec 31, 2017$7.59M-0.2%
FY2016Dec 31, 2016$7.60M+58.9%
FY2015Dec 31, 2015$4.79M-6.5%
FY2014Dec 31, 2014$5.12M+12.2%
FY2013Dec 31, 2013$4.56M+13.3%
FY2012Dec 31, 2012$4.03M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$948.00K+36.0%
Q1 FY2026Mar 31, 2026$563.00K-6.3%
Q4 FY2025Dec 31, 2025$700.00K+158.3%
Q3 FY2025Sep 30, 2025$655.00K+17.6%
Q2 FY2025Jun 30, 2025$697.00K+8.6%
Q1 FY2025Mar 31, 2025$601.00K-28.5%
Q4 FY2024Dec 31, 2024$271.00K-58.2%
Q3 FY2024Sep 30, 2024$557.00K+64.3%
Q2 FY2024Jun 30, 2024$642.00K-59.0%
Q1 FY2024Mar 31, 2024$840.00K+65.0%
Q4 FY2023Dec 31, 2023$648.00K-12.9%
Q3 FY2023Sep 30, 2023$339.00K-8.1%
Q2 FY2023Jun 30, 2023$1.57M+380.4%
Q1 FY2023Mar 31, 2023$509.00K+68.0%
Q4 FY2022Dec 31, 2022$744.00K+30.8%
Q3 FY2022Sep 30, 2022$369.00K+47.6%
Q2 FY2022Jun 30, 2022$326.00K+8.7%
Q1 FY2022Mar 31, 2022$303.00K-35.9%
Q4 FY2021Dec 31, 2021$569.00K+66.4%
Q3 FY2021Sep 30, 2021$250.00K-54.4%
Q2 FY2021Jun 30, 2021$300.00K-44.0%
Q1 FY2021Mar 31, 2021$473.00K-26.4%
Q4 FY2020Dec 31, 2020$342.00K-59.5%
Q3 FY2020Sep 30, 2020$548.00K-65.7%
Q2 FY2020Jun 30, 2020$536.00K-61.0%
Q1 FY2020Mar 31, 2020$643.00K-37.8%
Q4 FY2019Dec 31, 2019$845.00K-26.4%
Q3 FY2019Sep 30, 2019$1.60M+24.0%
Q2 FY2019Jun 30, 2019$1.38M+48.3%
Q1 FY2019Mar 31, 2019$1.03M+87.3%
Q4 FY2018Dec 31, 2018$1.15M+145.8%
Q3 FY2018Sep 30, 2018$1.29M-45.5%
Q2 FY2018Jun 30, 2018$928.00K-65.5%
Q1 FY2018Mar 31, 2018$552.00K-73.3%
Q4 FY2017Dec 31, 2017$467.00K-79.9%
Q3 FY2017Sep 30, 2017$2.36M+6.2%
Q2 FY2017Jun 30, 2017$2.69M–
Q1 FY2017Mar 31, 2017$2.07M–
Q4 FY2016Dec 31, 2016$2.32M–
Q3 FY2016Sep 30, 2016$2.23M–

More Harvard Apparatus Regenerative Technology figures

See a number that looks wrong?